Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03097393

Enrollment

Registered

2017-03-31

Start date

2014-01-01

Completion date

2017-03-01

Last updated

2017-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Brief summary

The aim of this study is to examine if procalcitonin (PCT) can be used for early prediction of AKI septic patients in ICU.

Detailed description

67 patients with sepsis were enrolled in this study. On admission, PCT was measured together with serum creatinine, urea, and other inflammatory markers. Quick Sepsis-related Organ Failure Assessment was calculated at the emergency department. Patients were classified into those with Acute kidney injury (AKI) and non-AKI groups.

Interventions

DIAGNOSTIC_TESTmeasure Serum procalcitonin level

measuring procalcitonin level

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* ICU patients with sepsis

Exclusion criteria

* Patient known to have End-stage kidney disease * Patients on Renal replacement therapy * patients without procalcitonin level within 24 hours from admission.

Design outcomes

Primary

Measure	Time frame	Description
development of AKI	28 Days	elevated kidney functions creatinine or oliguria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026